机构:[1]Department of Neurology,Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China[2]Department of Neurology,Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ[3]Department of Neurology,Xuan Wu Hospital of the Capital Medical University, and The Neurodegenerative Laboratory of Chinese Ministry of Education,神经内科首都医科大学宣武医院
In the wake of dramatic economic success during the past 2 decades, the specialized field of neurology has undergone a significant transformation in China. With an increase in life expectancy, the problems of aging and cognition have grown. Lifestyle alterations have been associated with an epidemiologic transition both in the incidence and etiology of stroke. These changes, together with an array of social issues and institution of health care reform, are creating challenges for practicing neurologists throughout China. Notable problems include overcrowded, decrepit facilities, overloaded physician schedules, deteriorating physician-patient relationships, and an insufficient infrastructure to accommodate patients who need specialized neurologic care. Conversely, with the creation of large and sophisticated neurology centers in many cities across the country, tremendous opportunities exist. Developments in neurologic subspecialties enable delivery of high-quality care. Clinical and translational research based on large patient populations as well as highly sophisticated technologies are emerging in many neurologic centers and pharmaceutical companies. Child neurology and neurorehabilitation will be fast-developing subdisciplines. Given China's extensive population, the growth and progress of its neurology complex, and its ever-improving quality control, it is reasonable to anticipate that Chinese neurologists will contribute notably to unraveling the pathogenic factors causing neurologic diseases and to providing new therapeutic solutions. Neurology (R) 2011;77:1986-1992
基金:
the National Natural Science Foundation of China (31170864 to and 30830045)
the Muscular Dystrophy Association of the United States (159281)
the Arizona Biomedical Research Commission (09–085)
the NIH (RO1AI083294 )
第一作者机构:[*2]Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, 350 W Thomas Road, Phoenix, AZ 85013
通讯作者:
通讯机构:[*1]Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300071, China[*2]Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, 350 W Thomas Road, Phoenix, AZ 85013[*3]Department of Neurology, Xuan Wu Hospital of the Capital Medical University, and The Neurodegenerative Laboratory of Chinese Ministry of Education, No.45 Changchun Street, Beijing 100053, China
推荐引用方式(GB/T 7714):
Fu-Dong Shi,Jian-ping Jia.Neurology and neurologic practice in China[J].NEUROLOGY.2011,77(22):1986-1992.doi:10.1212/WNL.0b013e31823a0ed3.
APA:
Fu-Dong Shi&Jian-ping Jia.(2011).Neurology and neurologic practice in China.NEUROLOGY,77,(22)
MLA:
Fu-Dong Shi,et al."Neurology and neurologic practice in China".NEUROLOGY 77..22(2011):1986-1992